MARSHALL WACE, LLP - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 28 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2021$3,0004980.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$294,0000.05%
Shaolin Capital Management LLC 275,000$1,034,0000.03%
Spectrum Management Group, LLC 5,030$19,0000.00%
Veritable, L.P. 43,551$164,0000.00%
ALPS ADVISORS INC 45,083$170,0000.00%
ETF MANAGERS GROUP, LLC 13,187$34,0000.00%
Qube Research & Technologies Ltd 24,179$91,0000.00%
NORTHERN TRUST CORP 44,476$167,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 301,110$1,132,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders